Please login to the form below
7
Revenue 2017Prevnar 13
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Prevnar 13 was produced by Pfizer.
Johns Hopkins and National Cancer Unit develop new genetic risk-scoring method for major diseases
Published in Nature Genetics and funded by the National Institutes of Health, CT-SLEB included over five million individuals across diverse populations to generate genetic scores for 13 traits, including coronary
CDC provides $262.5m to create national network for infectious diseases
The OADMN comprises 13 state health departments, organisations and academic and private sector partners, including Emory University, Northeastern University, the University of North Carolina at Chapel Hill and Kaiser Permanente Southern
CDC awards over $23m to Johns Hopkins Center for Health Security project
The Center for Health Security is one of 13 other organisations that accumulate the Outbreak Analytics and Disease Modelling Network.
Pfizer’s Litfulo approved by EC for adults and adolescents with severe alopecia areata
Results showed that 13.4% of adults and adolescents saw 90% or more scalp hair coverage after 24 weeks of treatment with Litfulo 50mg compared to 1.5% in the placebo
Almirall receives CHMP recommendation for lebrikizumab in atopic dermatitis
Almirall has announced that its IL-13 inhibitor lebrikizumab has been recommended by the European Medicines Agency’s human medicines committee to treat moderate-to-severe atopic dermatitis.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Top 10 benefits of virtual advisory boards: Save Time and Resources
- NIHR launches new framework to highlight health progress outcomes
- Johns Hopkins and National Cancer Unit develop new genetic risk-scoring method for major diseases
- UKHSA secures UK-based vaccine deal for future influenza pandemics
- Novo Nordisk and Valo Health agree deal worth up to $3.3bn to develop cardiovascular treatments
- Landscape review reveals £1.1bn of UK funding for rare diseases
No results were found
PMHub
nzyme
The nzyme group focuses on the three fundamentals that enable full patient access - Education, Access & Activation. Our specialist...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
